Project Publications

Printer-friendly versionPrinter-friendly version

1. Sack DA, Debes AK, Ateudjieu J, Bwire G, Ali M, Ngwa MC, et al. Contrasting Epidemiology of Cholera in Bangladesh and Africa. J Infect Dis. 2021.

2. Parvin I, Shahid A, Das S, Shahrin L, Ackhter MM, Alam T, et al. Vibrio cholerae O139 persists in Dhaka, Bangladesh since 1993. PLoS Negl Trop Dis. 2021;15(9):e0009721.

3. Ngwa MCI, C.; Okwor, T.J.;Yennan, S.; Williams, N.; Elimian, K.;Karaye, N.Y.;Bello, W.; Sack, D.A. The micro-hotspots of cholera in Kano State, Nigeria, 2010-2019—analysis of patient characteristics, Spatio-temporal patterns and contextual determinants at the ward level. medRxiv. 2021.

4. Mwaba J, Chisenga CC, Xiao S, Ng'ombe H, Banda E, Shea P, et al. Serum vibriocidal responses when second doses of oral cholera vaccine are delayed 6 months in Zambia. Vaccine. 2021;39(32):4516-23.

5. Debes AK, Shaffer AM, Ndikumana T, Liesse I, Ribaira E, Djumo C, et al. Cholera Hot-Spots and Contextual Factors in Burundi, Planning for Elimination. Trop Med Infect Dis. 2021;6(2).

6. Ngwa MC, Ihekweazu C, Okwor T, Yennan S, Williams N, Elimian K, et al. The cholera risk assessment in Kano State, Nigeria: A historical review, mapping of hotspots and evaluation of contextual factors. PLoS Negl Trop Dis. 2021;15(1):e0009046.

7. Bwire G, Orach CG, Aceng FL, Arianitwe SE, Matseketse D, Tumusherure E, et al. Refugee Settlements and Cholera Risks in Uganda, 2016-2019. Am J Trop Med Hyg. 2021.

8. Roskosky M, Ali M, Upreti SR, Sack D. Spatial clustering of cholera cases in the Kathmandu Valley: implications for a ring vaccination strategy. Int Health. 2021;13(2):170-7.

9. Mwaba J, Debes AK, Shea P, Mukonka V, Chewe O, Chisenga C, et al. Identification of cholera hotspots in Zambia: A spatiotemporal analysis of cholera data from 2008 to 2017. PLoS Negl Trop Dis. 2020;14(4):e0008227.

10. Nelson EJ, Grembi JA, Chao DL, Andrews JR, Alexandrova L, Rodriguez PH, et al. Gold Standard Cholera Diagnostics Are Tarnished by Lytic Bacteriophage and Antibiotics. J Clin Microbiol. 2020;58(9).

11. Ngwa MC, Alemu W, Okudo I, Owili C, Ugochukwu U, Clement P, et al. The reactive vaccination campaign against cholera emergency in camps for internally displaced persons, Borno, Nigeria, 2017: a two-stage cluster survey. BMJ Glob Health. 2020;5(6).

12. Ngwa MC, Wondimagegnehu A, Okudo I, Owili C, Ugochukwu U, Clement P, et al. The multi-sectorial emergency response to a cholera outbreak in Internally Displaced Persons camps in Borno State, Nigeria, 2017. BMJ Glob Health. 2020;5(1):e002000.

13. Bwire G, Roskosky M, Ballard A, Brooks WA, Okello A, Rafael F, et al. Use of surveys to evaluate an integrated oral cholera vaccine campaign in response to a cholera outbreak in Hoima district, Uganda. BMJ Open. 2020;10(12):e038464.

14. Ramamurthy T, Das B, Chakraborty S, Mukhopadhyay AK, Sack DA. Diagnostic techniques for rapid detection of Vibrio cholerae O1/O139. Vaccine. 2020;38 Suppl 1:A73-A82.

15. Roskosky M, Acharya B, Shakya G, Karki K, Sekine K, Bajracharya D, et al. Feasibility of a Comprehensive Targeted Cholera Intervention in The Kathmandu Valley, Nepal. Am J Trop Med Hyg. 2019;100(5):1088-97.

16. Sack DA. Enhancing immune responses to oral vaccines: still an enigma. Lancet Infect Dis. 2019;19(2):122-3.

17. Benard AHM, Guenou E, Fookes M, Ateudjieu J, Kasambara W, Siever M, et al. Whole genome sequence of Vibrio cholerae directly from dried spotted filter paper. PLoS Negl Trop Dis. 2019;13(5):e0007330.

18. Grandesso F, Kasambara W, Page AL, Debes AK, M'Bang'ombe M, Palomares A, et al. Effectiveness of oral cholera vaccine in preventing cholera among fishermen in Lake Chilwa, Malawi: A case-control study. Vaccine. 2019;37(28):3668-76.

19. Iyer AS, Azman AS, Bouhenia M, Deng LO, Anderson CP, Graves M, et al. Dried Blood Spots for Measuring Vibrio cholerae-specific Immune Responses. PLoS Negl Trop Dis. 2018;12(1):e0006196.

20. Bwire G, Sack DA, Almeida M, Li S, Voeglein JB, Debes AK, et al. Molecular characterization of Vibrio cholerae responsible for cholera epidemics in Uganda by PCR, MLVA and WGS. PLoS Negl Trop Dis. 2018;12(6):e0006492.

21. Lopez AL, Deen J, Azman AS, Luquero FJ, Kanungo S, Dutta S, et al. Immunogenicity and Protection From a Single Dose of Internationally Available Killed Oral Cholera Vaccine: A Systematic Review and Metaanalysis. Clin Infect Dis. 2018;66(12):1960-71.

22. Sack DA, Ali M. Protection from killed oral cholera vaccine continues for 4 years. The Lancet Global health. 2018;6(9):e946-e7.

23. Bwire G, Debes AK, Orach CG, Kagirita A, Ram M, Komakech H, et al. Environmental Surveillance of Vibrio cholerae O1/O139 in the Five African Great Lakes and Other Major Surface Water Sources in Uganda. Front Microbiol. 2018;9:1560.

24. Bliss J, Bouhenia M, Hale P, Couturier BA, Iyer AS, Rumunu J, et al. High Prevalence of Shigella or Enteroinvasive Escherichia coli Carriage among Residents of an Internally Displaced Persons Camp in South Sudan. Am J Trop Med Hyg. 2018;98(2):595-7.

25. Ali M, Nelson A, Luquero FJ, Azman AS, Debes AK, M'Bang'ombe M M, et al. Safety of a killed oral cholera vaccine (Shanchol) in pregnant women in Malawi: an observational cohort study. Lancet Infect Dis. 2017.

26. Luquero FJ, Ballard A, Sack DA. Ensuring access to oral cholera vaccine to those who need them most. Vaccine. 2017;35(3):411.

27. Bwire G, Orach CG, Abdallah D, Debes AK, Kagirita A, Ram M, et al. Alkaline peptone water enrichment with a dipstick test to quickly detect and monitor cholera outbreaks. BMC Infect Dis. 2017;17(1):726.

28. Yakum MN, Ateudjieu J, Guenou E, Walter EA, Ram M, Debes AK, et al. Health seeking behaviour among suspected cases of cholera in Cameroonian health districts in Lake Chad basin. BMC Res Notes. 2017;10(1):433.

29. Ali M, Sen Gupta S, Arora N, Khasnobis P, Venkatesh S, Sur D, et al. Identification of burden hotspots and risk factors for cholera in India: An observational study. PLoS One. 2017;12(8):e0183100.

30. von Seidlein L, Sack D, Azman AS, Ivers LC, Lopez AL, Deen JL. Cholera outbreak in Yemen. Lancet Gastroenterol Hepatol. 2017;2(11):777.

31. Bwire G, Ali M, Sack DA, Nakinsige A, Naigaga M, Debes AK, et al. Identifying cholera "hotspots" in Uganda: An analysis of cholera surveillance data from 2011 to 2016. PLoS Negl Trop Dis. 2017;11(12):e0006118.

32. Debes AK, Ateudjieu J, Guenou E, Ebile W, Sonkoua IT, Njimbia AC, et al. Clinical and Environmental Surveillance for Vibrio cholerae in Resource Constrained Areas: Application During a 1-Year Surveillance in the Far North Region of Cameroon. Am J Trop Med Hyg. 2016.

33. Debes AK, Ateudjieu J, Guenou E, Lopez AL, Bugayong MP, Retiban PJ, et al. Evaluation in Cameroon of a Novel, Simplified Methodology to Assist Molecular Microbiological Analysis of V. cholerae in Resource-Limited Settings. PLoS Negl Trop Dis. 2016;10(1):e0004307.

34. Deen J, von Seidlein L, Luquero FJ, Troeger C, Reyburn R, Lopez AL, et al. The scenario approach for countries considering the addition of oral cholera vaccination in cholera preparedness and control plans. Lancet Infect Dis. 2016;16(1):125-9.

35. Ontweka LN, Deng LO, Rauzier J, Debes AK, Tadesse F, Parker LA, et al. Cholera Rapid Test with Enrichment Step Has Diagnostic Performance Equivalent to Culture. PLoS One. 2016;11(12):e0168257.

36. Iyer AS, Bouhenia M, Rumunu J, Abubakar A, Gruninger RJ, Pita J, et al. Immune Responses to an Oral Cholera Vaccine in Internally Displaced Persons in South Sudan. Scientific reports. 2016;6:35742.

37. Azman AS, Parker LA, Rumunu J, Tadesse F, Grandesso F, Deng LL, et al. Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study. The Lancet Global health. 2016;4(11):e856-e63.

38. Azman AS, Rumunu J, Abubakar A, West H, Ciglenecki I, Helderman T, et al. Population-Level Effect of Cholera Vaccine on Displaced Populations, South Sudan, 2014. Emerg Infect Dis. 2016;22(6):1067-70.

39. Deen J, Sack DA. The opportunities & challenges in delivering oral cholera vaccines. Indian J Med Res. 2016;144(2):149-50.

40. Djouma FN, Ateudjieu J, Ram M, Debes AK, Sack DA. Factors Associated with Fatal Outcomes Following Cholera-Like Syndrome in Far North Region of Cameroon: A Community-Based Survey. Am J Trop Med Hyg. 2016;95(6):1287-91.

41. Debes AK, Ali M, Azman AS, Yunus M, Sack DA. Cholera cases cluster in time and space in Matlab, Bangladesh: implications for targeted preventive interventions. Int J Epidemiol. 2016;45(6):2134-9.

42. Ali M, Debes AK, Luquero FJ, Kim DR, Park JY, Digilio L, et al. Potential for Controlling Cholera Using a Ring Vaccination Strategy: Re-analysis of Data from a Cluster-Randomized Clinical Trial. PLoS Med. 2016;13(9):e1002120.

43. Ali M, Nelson AR, Lopez AL, Sack DA. Updated global burden of cholera in endemic countries. PLoS Negl Trop Dis. 2015;9(6):e0003832.

44. Luquero FJ, Sack DA. Effectiveness of oral cholera vaccine in Haiti. The Lancet Global health. 2015;3(3):e120-1.

45. Hall RH, Sack DA. Introducing cholera vaccination in Asia, Africa and Haiti: a meeting report. Vaccine. 2015;33(4):487-92.

46. Azman AS, Luquero FJ, Ciglenecki I, Grais RF, Sack DA, Lessler J. The Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study. PLoS Med. 2015;12(8):e1001867.

47. Abubakar A, Azman AS, Rumunu J, Ciglenecki I, Helderman T, West H, et al. The First Use of the Global Oral Cholera Vaccine Emergency Stockpile: Lessons from South Sudan. PLoS Med. 2015;12(11):e1001901.

48. Deen J, Ali M, Sack D. Methods to assess the impact of mass oral cholera vaccination campaigns under real field conditions. PLoS One. 2014;9(2):e88139.

49. Troeger C, Sack DA, Chao DL. Evaluation of targeted mass cholera vaccination strategies in Bangladesh: a demonstration of a new cost-effectiveness calculator. Am J Trop Med Hyg. 2014;91(6):1181-9.

50. Sack DA. A new era in the history of cholera: the road to elimination. Int J Epidemiol. 2013;42(6):1537-40.

51. Chakraborty S, Alam M, Scobie HM, Sack DA. Adaptation of a simple dipstick test for detection of Vibrio cholerae O1 and O139 in environmental water. Front Microbiol. 2013;4:320